CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Planned sale Senior Vice President, Finance sold 10,000 shares at an average $106.66 ($1,066,572)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $86.28 ($603,938)
- 4 Planned sale Senior Vice President, Finance sold 9,999 shares at an average $84.63 ($846,180)
- 4 Open-market sale Director sold 3,553,410 shares at $84.43 ($300,014,406)
- 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $94.42 ($472,079)
- 4 Planned sale Senior Vice President, Finance sold 1,587 shares at an average $80.95 ($128,468)
- 4 Planned sale Senior Vice President, Finance sold 9,854 shares at an average $69.72 ($687,035)
- 4 Planned sale Chief Medical Officer sold 7,947 shares at an average $69.28 ($550,607)
- 4 Open-market sale Chief Executive Officer sold 1,729 shares at $69.69 ($120,494)
- 4 Open-market sale Chief Operating Officer sold 600 shares at $69.69 ($41,814)
- 4 Open-market sale General Counsel sold 733 shares at $69.69 ($51,083)
- 4 Planned sale Director sold 35,000 shares at an average $70.13 ($2,454,382)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 105,000 shares at an average $58.97 ($6,191,366)
- 4 Planned sale Senior Vice President, Finance sold 10,290 shares at an average $59.07 ($607,806)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)
Page 2 of 23 · 458 filings